patients' blood sugar control without increasing the risk of low blood
sugar (hypoglycemia) in patients with type 2 diabetes, according to the
results of a phase 2 clinical trial.
nathan hale kohls coupons joe kapp joe kapp kohls target target
Monday, February 27, 2012
Experimental Drug Shows Promise Against Type 2 Diabetes (HealthDay)
[unable to retrieve full-text content]HealthDay - SUNDAY, Feb. 26 (HealthDay News) -- An experimental drug improves
patients' blood sugar control without increasing the risk of low blood
sugar (hypoglycemia) in patients with type 2 diabetes, according to the
results of a phase 2 clinical trial.
patients' blood sugar control without increasing the risk of low blood
sugar (hypoglycemia) in patients with type 2 diabetes, according to the
results of a phase 2 clinical trial.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.